PTEN and prostate carcinoma: USP14 inhibits non-homologous DNA end joining (NHEJ) and increases cell death in response to IR in phosphatase and tensin homolog (PTEN)-deficient prostate cancer cells through targeting several NHEJ-associated proteins, including Ku70, Ku80, and ring finger protein 168 (RNF168).